JP2023529844A5 - - Google Patents

Info

Publication number
JP2023529844A5
JP2023529844A5 JP2022574471A JP2022574471A JP2023529844A5 JP 2023529844 A5 JP2023529844 A5 JP 2023529844A5 JP 2022574471 A JP2022574471 A JP 2022574471A JP 2022574471 A JP2022574471 A JP 2022574471A JP 2023529844 A5 JP2023529844 A5 JP 2023529844A5
Authority
JP
Japan
Prior art keywords
seq
domain
amino acid
fusion protein
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022574471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023529844A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/035937 external-priority patent/WO2021248023A2/en
Publication of JP2023529844A publication Critical patent/JP2023529844A/ja
Publication of JP2023529844A5 publication Critical patent/JP2023529844A5/ja
Pending legal-status Critical Current

Links

JP2022574471A 2020-06-05 2021-06-04 エピゲノム編集のための組成物及び方法 Pending JP2023529844A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063035431P 2020-06-05 2020-06-05
US63/035,431 2020-06-05
US202063118832P 2020-11-27 2020-11-27
US63/118,832 2020-11-27
PCT/US2021/035937 WO2021248023A2 (en) 2020-06-05 2021-06-04 Compositions and methods for epigenome editing

Publications (2)

Publication Number Publication Date
JP2023529844A JP2023529844A (ja) 2023-07-12
JP2023529844A5 true JP2023529844A5 (cg-RX-API-DMAC10.html) 2024-06-11

Family

ID=78831718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022574471A Pending JP2023529844A (ja) 2020-06-05 2021-06-04 エピゲノム編集のための組成物及び方法

Country Status (12)

Country Link
US (1) US20230212323A1 (cg-RX-API-DMAC10.html)
EP (1) EP4162054A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023529844A (cg-RX-API-DMAC10.html)
KR (1) KR20230021081A (cg-RX-API-DMAC10.html)
CN (1) CN116057180A (cg-RX-API-DMAC10.html)
AU (1) AU2021282659A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022024747A2 (cg-RX-API-DMAC10.html)
CA (1) CA3184882A1 (cg-RX-API-DMAC10.html)
GB (1) GB2612466B (cg-RX-API-DMAC10.html)
IL (1) IL298605A (cg-RX-API-DMAC10.html)
MX (1) MX2022015284A (cg-RX-API-DMAC10.html)
WO (1) WO2021248023A2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113846019B (zh) * 2021-03-05 2023-08-01 海南师范大学 一种海洋微拟球藻靶向表观基因组遗传调控方法
EP4522735A1 (en) * 2022-05-13 2025-03-19 Integra Therapeutics Use of transposases for improving transgene expression and nuclear localization
JP2026506083A (ja) 2023-02-17 2026-02-20 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ エピジェネティック修飾を行うための組成物および方法
WO2024238682A2 (en) * 2023-05-15 2024-11-21 The Regents Of The University Of California Cask gene editing system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037001A2 (en) * 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
DK3178835T3 (da) * 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
CN105408483A (zh) * 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
AU2015298571B2 (en) * 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US20190100732A1 (en) * 2016-06-02 2019-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
AU2017327384B2 (en) * 2016-09-13 2021-05-20 The Jackson Laboratory Targeted enhanced DNA demethylation
AU2018213044B2 (en) * 2017-01-26 2024-08-01 The Regents Of The University Of California Targeted gene demethylation in plants
AU2019255789B2 (en) * 2018-04-19 2025-11-20 The Regents Of The University Of California Compositions and methods for gene editing

Similar Documents

Publication Publication Date Title
JP2023529611A5 (cg-RX-API-DMAC10.html)
US20240254455A1 (en) Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins
JP2023516226A5 (cg-RX-API-DMAC10.html)
US20190382775A1 (en) Truncated crispr-cas proteins for dna targeting
US10233218B2 (en) Peptides for the specific binding of RNA targets
JP2024535672A5 (cg-RX-API-DMAC10.html)
GB2612212A (en) Compositions and methods for gene editing
JP2023501223A5 (cg-RX-API-DMAC10.html)
JP2023506765A5 (cg-RX-API-DMAC10.html)
JP2022552409A5 (cg-RX-API-DMAC10.html)
JP2021522783A5 (cg-RX-API-DMAC10.html)
Reiter et al. Gene expression in archaebacteria: physical mapping of constitutive and UV-inducible transcripts from the Sulfolobus virus-like particle SSV1
KR20230025951A (ko) 후성적으로 조절되는 부위-특이적 뉴클레아제
JP2023549339A5 (cg-RX-API-DMAC10.html)
JP2018528237A5 (cg-RX-API-DMAC10.html)
Zhu et al. Using defined finger–finger interfaces as units of assembly for constructing zinc-finger nucleases
GB2612466A (en) Compositions and methods for epigenome editing
JP2024511131A5 (cg-RX-API-DMAC10.html)
JP2023515670A5 (cg-RX-API-DMAC10.html)
JP2022528010A5 (cg-RX-API-DMAC10.html)
JP2024511163A5 (cg-RX-API-DMAC10.html)
JP2024543042A5 (cg-RX-API-DMAC10.html)
JP2024542995A5 (cg-RX-API-DMAC10.html)
JP2024533316A5 (cg-RX-API-DMAC10.html)
CN114144519A (zh) 单碱基置换蛋白以及包含其的组合物